Authors: Underhill, CR Parnis, FX Highley, MS Ahern, J Harper, PG Hansen, H Lund, B Dombernowsky, P Hirsch, F Hansen, M Carmichael, J Williams, C

Citation: Cr. Underhill et al., Multicenter phase II study of gemcitabine in previously untreated patientswith advanced epithelial ovarian cancer, ANTI-CANC D, 12(8), 2001, pp. 647-652

Authors: Highley, MS Calvert, AH

Citation: Ms. Highley et Ah. Calvert, Clinical experience with cisplatin and carboplatin, CANC DRUG, 7, 2000, pp. 171-194

Authors: Stone, M Highley, MS Harper, PG Poole, D

Citation: M. Stone et al., Awareness of BACUP in primary health care: the potential of voluntary services, BR J GEN PR, 49(441), 1999, pp. 315-316

Authors: Highley, MS Underhill, CR Parnis, FX Karapetis, C Rankin, E Dussek, J Bryant, B Rowland, C Hodson, N Hughes, J Harper, PG

Citation: Ms. Highley et al., Treatment of invasive thymoma with single-agent ifosfamide, J CL ONCOL, 17(9), 1999, pp. 2737-2744

Authors: Highley, MS van Oosterom, AT Maes, RA De Bruijn, EA

Citation: Ms. Highley et al., Intravesical drug delivery - Pharmacokinetic and clinical considerations, CLIN PHARMA, 37(1), 1999, pp. 59-73

Authors: Van Der Heyden, SAM Highley, MS De Bruijn, EA Tjaden, UR Reeuwijk, HJEM Van Slooten, H Van Oosterom, AT Maes, RAA

Citation: Sam. Van Der Heyden et al., Pharmacokinetics and bioavailability of oral 5 '-deoxy-5-fluorouridine in cancer patients, BR J CL PH, 47(4), 1999, pp. 351-356